Off Patent
August 2027

Vistogard

uridine triacetate

BTG International Inc

Granule (oral) · NDA 208159

Last listed protection ends
August 17, 2027

The FDA lists 1 patent for Vistogard, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,776,838
    Claims a use (U-1791)